| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 02/04/2004 | CN1473051A Use of immidazoquinolinamines as adjuvants in DNA vaccination |
| 02/03/2004 | US6686376 Methods and compounds for inhibiting MRP1 |
| 02/03/2004 | US6686353 Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists |
| 02/03/2004 | CA2355987C Bicyclic amide derivatives and their use as muscle relaxants |
| 01/29/2004 | WO2004009584A1 Novel p-glycoprotein inhibitor, method for preparing same and oral composition comprising same |
| 01/29/2004 | WO2004009552A1 Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogs |
| 01/29/2004 | WO2004009527A1 Materials and methods for treating hypercholesterolemia |
| 01/29/2004 | WO2004009017A2 Modulators of the glucocorticoid receptor and method |
| 01/29/2004 | WO2003053971A8 Pyridoquinoxaline antivirals |
| 01/29/2004 | US20040019216 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 01/29/2004 | US20040019214 Carbocyclic carbo, oxo amines such as N-heptyl-3-methyl-4-oxo -1,4-dihydroquinoline-2-carboxamide, used for prophylaxis of gastrointerstinal disorders |
| 01/29/2004 | US20040019113 Phosphate transport inhibitors |
| 01/29/2004 | US20040019103 Method of enhancing cellular production of molecular chaperon, hydroxylamine derivatives useful for enhancing the chaperon production and the preparation thereof |
| 01/29/2004 | US20040018192 Integrin expression inhibitors |
| 01/29/2004 | CA2492907A1 Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogs |
| 01/29/2004 | CA2492906A1 Materials and methods for treating hypercholesterolemia |
| 01/28/2004 | EP1384712A1 Derivatives of N-((quinolinyl)oxy)-phenyl)-urea and N-((quinazolinyl)oxy)-phenyl)-urea with antitumor activity |
| 01/28/2004 | EP1383734A2 Compounds useful as intermediates for 4-aminoquinoline derivatives |
| 01/28/2004 | EP1313706A4 Method for synthesizing flosequinan from 4-fluoroanthranilic acid |
| 01/28/2004 | CN1471513A 农业化学组合物 Agricultural chemical composition |
| 01/28/2004 | CN1471508A Selective androgen receptor modulators and methods of use thereof |
| 01/28/2004 | CN1470237A Use of chloroquine, hydroxychloroquine and 4-aminoquinazine derivatives in preparing medicine for antiretrovirus therapy |
| 01/28/2004 | CN1136216C Pyrone carboxy Lic acid derivative or lts salt and antibiotic with the same us effective component |
| 01/28/2004 | CN1136198C Novel benzyl pyrimidines |
| 01/28/2004 | CN1136193C Imide derivatives ar Salts thereof |
| 01/28/2004 | CN1136183C Process for producing optically active mevalonolactone compound |
| 01/27/2004 | US6683648 Enzyme inhibitors such as 2s-(((dimethylamino)acetyl)amino)-n-(3-((((2-hydroxy-1,1 -dimethylethyl)amino)sulfonyl)(3-methyl butyl)amino)-2r-hydroxy-1s-(phenylmethyl)-propyl)-3,3-dimethyl butanamide, used for prohylaxis of viral diseases |
| 01/27/2004 | US6683211 Fungicides for crops |
| 01/27/2004 | US6683201 Analine derivatives as OSC inhibitors |
| 01/27/2004 | US6683092 [3-(c5-14alkyl-2-oxo-1,2,3,4-tetrahydro-quinolin-6-yl)-3-oxo-propenyl]-phenyl and [3-(c5-14alkyl-2-oxo-1,2,3,4- tetrahydro-quinolin-6-yl)-3-oxo-propenyl]-heteroaryl derivatives having anti-tumor activity |
| 01/27/2004 | US6683091 Heterocyclic sulfanamides; alzheimer's disease; preventing deposition of amyloid protein |
| 01/27/2004 | US6683074 Cyclic amine derivatives-CCR-3 receptor antagonists |
| 01/27/2004 | US6683068 For therapy of tetracycline compound-responsive states, such as bacterial infections and neoplasms |
| 01/27/2004 | US6682782 Organic compound having an acetylene group, vacuum deposition polymerization thereof, deposited polymerized thin film, and electroluminescence device containing same |
| 01/22/2004 | WO2004007461A1 8-hydroxy quinoline derivatives |
| 01/22/2004 | WO2004007460A1 Process for producing 2,3,6-trialkyl-8-fluoro-4-quinoline derivative |
| 01/22/2004 | WO2004007459A2 Naphthol, quinoline and isoquinoline-derivatives as modulators of vanilloid vr1 receptor |
| 01/22/2004 | WO2003062202A3 Method for the production of substituted 1,2,3,4-tetrahydroisoquinoline-2-carboxylic acids |
| 01/22/2004 | WO2003024395A8 Linked biaryl compounds |
| 01/22/2004 | US20040014975 For contraception, treatment of hormone-related (aging) conditions, and sexual dysfunction |
| 01/22/2004 | US20040014972 Such as 4-(4-(quinolin-8-yl)piperazin-1-yl)-1-(4-fluorophenyl) butan-1-one trichloride dihydrate; HT3 receptor antagonists |
| 01/22/2004 | US20040014796 Antiinflammatory agents; rheumatic diseases; antitumor agents |
| 01/22/2004 | US20040014784 Substituted propargylamines |
| 01/22/2004 | US20040014774 Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase |
| 01/22/2004 | US20040014743 Mbreast and prostate anticancer agents; viricides; alopecia |
| 01/21/2004 | EP1382598A1 Novel heterocyclic derivatives |
| 01/21/2004 | EP1382597A2 Steroid receptor modulator compounds and methods |
| 01/21/2004 | EP0942723B1 4-aryl-3-hydroxyquinolin-2-one derivatives as ion channel modulators |
| 01/21/2004 | CN1469878A Aza-and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors |
| 01/21/2004 | CN1469864A Process for preparing cilostazol |
| 01/21/2004 | CN1469862A 2,2-diphenyl butanamide derivatives and medicines containing the same |
| 01/21/2004 | CN1469857A Method of producing carboxylic acid salts |
| 01/21/2004 | CN1469745A Preventives and remedies for complications of diabetes |
| 01/21/2004 | CN1468852A Iridium catalyzed enantiotropic hydrosubstituting process of aromatic pyridine ring and pyrazine ring |
| 01/20/2004 | US6680386 Process for preparing 2-(4-chlorobenzoylamino)-3-[2 (1H)-quinolinon-4-yl] propionic acid |
| 01/20/2004 | US6680321 4-((1-piperazinylmethyl)-benzamide derivatives; hypotensive agents; immunomodulators |
| 01/20/2004 | US6680282 Fungicide having an excellent control effect; 4-quinolinol derivatives having specific substituent at 1,2 and atleast one substituent at 5,6,7,8 position |
| 01/20/2004 | CA2116782C 1-substituted 1h-imidazo¬4,5-c|quinolin-4-amines; intermediate and pharmaceutical compositions |
| 01/16/2004 | CA2393734A1 Quinolinium- and pyridinium- based fluorescent dye compounds |
| 01/15/2004 | WO2004005280A1 Novel quinolinic compounds showing a feature of excited-state intramolecular proton transfer (esipt) |
| 01/15/2004 | WO2004005279A2 Substituted anthranilic amide derivatives and methods of use |
| 01/15/2004 | WO2004005261A1 1-aralkyl-n-(3-quinolyl)-1-cyclohexanecarboxamide derivative |
| 01/15/2004 | WO2004005260A1 A-`7-halo-2-quino (xa-) linyloxy!phenoxy-propionic acid derivatives as antineoplastic agents |
| 01/15/2004 | WO2004004778A1 Use of cetp inhibitors and optionally hmg coa reductable inhibitors and/or antihypertensive agents |
| 01/15/2004 | WO2004004726A1 Mchir antagonists |
| 01/15/2004 | WO2004004703A1 m-PHENYLENEDIAMINE DERIVATIVE |
| 01/15/2004 | WO2004004651A2 Therapeutic amides |
| 01/15/2004 | US20040010148 Antiinflammatory agents, antiallergens, antiproliferative agents, immunosuppressants, antidiabetic agents, cardiovascular disorders |
| 01/15/2004 | US20040009989 Novel crystalline forms of gatifloxacin |
| 01/15/2004 | US20040009985 Bicyclo 4.4.0 antiviral derivatives |
| 01/15/2004 | US20040009977 For use in the prophylaxis and the treatment of Picornavirus and human rotavirus infections. |
| 01/15/2004 | CA2491835A1 Mch1r antagonists |
| 01/15/2004 | CA2489166A1 Substituted anthranilic amide derivatives and methods of use |
| 01/15/2004 | CA2488736A1 Use of cetp inhibitors and optionally hmg coa reductase inhibitors and/or antihypertensive agents |
| 01/14/2004 | EP1380575A1 1,2-disubstituted 1,4-dihydro-4-oxoquinoline compounds |
| 01/14/2004 | EP1380562A1 Carboxylic acid derivative and salt thereof |
| 01/14/2004 | EP1379517A2 Abca-1 elevating compounds against coronary artery disease or atherosclerosis |
| 01/14/2004 | EP1379510A1 Aryl and heteroaryl urea chk1 inhibitors for use as radiosensitizers and chamosensitizers |
| 01/14/2004 | EP1379508A2 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof |
| 01/14/2004 | EP1379507A1 HETEROARYL UREAS CONTAINING NITROGEN HETERO-ATOMS AS p38 KINASE INHIBITORS |
| 01/14/2004 | EP1379505A2 Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas |
| 01/14/2004 | EP1379493A2 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses |
| 01/14/2004 | CN1468227A Non-imidazole aryloxyalkylamines |
| 01/14/2004 | CN1468224A Derivatives of quinoline as alpha-2 antagonists |
| 01/14/2004 | CN1468223A Process for producign optically active ethyl (3r,5s,6e)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxy-6-heptenoate |
| 01/14/2004 | CN1468221A Non-imidazole aryloxypiperidines |
| 01/14/2004 | CN1468214A Novel derivatives of aminocyclohexane |
| 01/14/2004 | CN1468211A Nitroso diphenylamine derivatives |
| 01/14/2004 | CN1134411C Bicyclic amino derivatives and PGD2 antagonist containing same |
| 01/13/2004 | US6677339 S-3-(4-(3,5-dichloropyrid-4-ylcarboxamido)phenyl)-2-(4,6-dimet hoxy-1,3,5-triazin-2-ylamino)propanoic acid for example; inhibit binding of alpha 4 integrins to their ligands, for treating immune or inflammatory disorders |
| 01/13/2004 | CA2049162C Ortho-substituted phenylacetamides |
| 01/08/2004 | WO2004002977A1 Inhibitors of hcv ns5b polymerase |
| 01/08/2004 | WO2004002965A1 Arylcarbonylpiperazines and heteroarylcarbonylpiperazines and the use thereof for treating benign and malignant tumour diseases |
| 01/08/2004 | WO2004002960A1 Substituted quinoline ccr5 receptor antagonists |
| 01/08/2004 | WO2004002956A2 Asymmetric synthesis of amino-pyrrolidinones and a crystalline, free-base amino-pyrrolidinone |
| 01/08/2004 | WO2004002484A1 Phosphodiesterase inhibitor |
| 01/08/2004 | WO2003087088A3 (condensed) pyrimidone and (condensed) pyridone compounds, processes for their preparation, and pharmaceutical compositions containing them |
| 01/08/2004 | WO2003047515A3 P2x7 receptor antagonists |
| 01/08/2004 | US20040006236 Diaminopropionic acid derivatives |
| 01/08/2004 | US20040006141 Amidocarboxylic acid compounds |